HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katalin Hanto Selected Research

HO-3538

9/2006A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katalin Hanto Research Topics

Disease

2Infarction (Infarctions)
09/2006 - 12/2003
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2009
1Ischemia
01/2009
1Wounds and Injuries (Trauma)
09/2006
1Reperfusion Injury
09/2006
1Fibrosis (Cirrhosis)
07/2006
1Cardiomegaly (Heart Hypertrophy)
07/2006
1Heart Failure
07/2006
1Hypertrophy
07/2006
1Myocardial Infarction
07/2006
1Ventricular Remodeling
07/2006
1Necrosis
10/2005

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2009 - 07/2006
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2009 - 10/2005
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2009
1Metoprolol (Toprol-XL)FDA LinkGeneric
01/2009
1Phosphotransferases (Kinase)IBA
01/2009
1beta Adrenergic ReceptorsIBA
01/2009
1Verapamil (Calan)FDA LinkGeneric
01/2009
1HO-3538IBA
09/2006
1CalciumIBA
09/2006
1Proteins (Proteins, Gene)FDA Link
09/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2006
1Protein Kinase C-epsilonIBA
07/2006
12- ((2- piperidin- 1- ylethyl)thio)quinazolin- 4(3H)- oneIBA
07/2006
1Glycogen Synthase Kinase 3 betaIBA
07/2006
1CollagenIBA
07/2006
1EnzymesIBA
07/2006
1Glycogen Synthase (Synthase I)IBA
07/2006
1Isoproterenol (Isoprenaline)FDA LinkGeneric
07/2006
1Protein Kinase CIBA
07/2006
1Mitogen-Activated Protein KinasesIBA
07/2006
1Adenosine Triphosphate (ATP)IBA
10/2005
1WortmanninIBA
12/2003
1HO3073IBA
12/2003

Therapy/Procedure

1Therapeutics
01/2009